Precision healthcare milestone reached as FDA clears new multimarker medical laboratory test to detect antibiotic-resistant bacteria
from DARK Daily
Clearance by the Food and Drug Administration of a new rapid, multimarker genetic test designed to identify bacteria that are resistant to carbapenem antibiotics was considered significant enough that the federal agency issued a press release announcing that the test was cleared and now available for use by physicians and clinical laboratories in the United States. In the race to develop molecular assays and genetic tests for infectious disease that deliver improved sensitivity and specificity with a faster time-to-answer, this new test offers all three benefits.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063